Related Experiment Video

Updated: Jun 26, 2026

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
09:37

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

Cardiac and systemic haemodynamic complications of liver cirrhosis

Jens H Henriksen1, Søren Møller

  • 1Department of Clinical Physiology 239, Hvidovre Hospital, Faculty of Health Sciences, University of Copenhagen, Hvidovre, Denmark. jens.h.henriksen@hvh.regionh.dk

Scandinavian Cardiovascular Journal : SCJ
|January 16, 2009
PubMed

Insights

Liver cirrhosis causes cardiovascular issues like cirrhotic cardiomyopathy, affecting heart function. Improving liver health can reverse these cardiac complications, though specific treatments are still under research.

Area of Science:

  • Cardiology
  • Hepatology
  • Internal Medicine

Background:

  • Liver cirrhosis leads to significant cardiovascular complications, including cardiac dysfunction and circulatory abnormalities.
  • These complications arise from the body's complex regulatory responses to the disease, resulting in widespread vasodilation and altered hemodynamic resistance.
  • Cirrhotic cardiomyopathy, distinct from alcoholic heart muscle disease, presents with systolic, diastolic, and electrophysiological dysfunction, often remaining subclinical until stressed.

Purpose of the Study:

  • To review the cardiovascular complications associated with liver cirrhosis.
  • To highlight the entity of cirrhotic cardiomyopathy and its clinical implications.
  • To discuss the current understanding of management strategies for cardiac failure in cirrhotic patients.

Main Methods:

  • Literature review of cardiovascular complications in liver cirrhosis.
  • Analysis of the pathophysiology of cirrhotic cardiomyopathy.
  • Discussion of clinical presentation, diagnosis, and management principles.

Main Results:

  • Cardiovascular complications encompass cardiac dysfunction and circulatory changes (central, splanchnic, peripheral).
  • Cirrhotic cardiomyopathy is characterized by systolic and diastolic dysfunction and electrophysiological abnormalities.
  • Cardiac failure is a critical factor in mortality following liver transplantation and invasive procedures like TIPS.

Conclusions:

  • Cardiovascular complications are integral to liver cirrhosis and can be reversed with improved liver function.
  • Cirrhotic cardiomyopathy requires careful consideration, especially during stressful medical interventions.
  • Current management focuses on standard heart failure treatments with specific precautions for ACE inhibitors and angiotensin antagonists.

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...